Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue, net $ 566,000 $ 1,153,000
Cost of revenue 504,000 858,000
Gross profit 62,000 295,000
Operating Expenses:    
Research and development 1,537,000 1,173,000
Sales and marketing 1,300,000 874,000
General and administrative 1,126,000 968,000
Total operating expenses 3,963,000 3,015,000
Loss from operations (3,901,000) (2,720,000)
Interest expense (1,000) (3,000)
Other expense (2,000) (2,000)
Warrant inducement expense 0 (567,000)
Loss before provision for income taxes (3,904,000) (3,292,000)
Provision for income taxes 0 0
Net loss (3,904,000) (3,292,000)
Convertible preferred stock dividend 0 (20,000)
Net loss attributable to common stockholders $ (3,904,000) $ (3,312,000)
Net loss per common share - Basic $ (0.26) $ (0.33)
Net loss per common share - Diluted $ (0.26) $ (0.33)
Weighted average number of common shares used in computing net loss per common share - Basic 14,828,888 9,979,991
Weighted average number of common shares used in computing net loss per common share - Diluted 14,828,888 9,979,991